These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6198281)

  • 1. Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies.
    Oguma K; Murayama S; Syuto B; Iida H; Kubo S
    Infect Immun; 1984 Feb; 43(2):584-8. PubMed ID: 6198281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum.
    Oguma K; Agui T; Syuto B; Kimura K; Iida H; Kubo S
    Infect Immun; 1982 Oct; 38(1):14-20. PubMed ID: 6183207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin.
    Tsuzuki K; Yokosawa N; Syuto B; Ohishi I; Fujii N; Kimura K; Oguma K
    Infect Immun; 1988 Apr; 56(4):898-902. PubMed ID: 2450068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.
    Ochanda JO; Syuto B; Oguma K; Iida H; Kubo S
    Appl Environ Microbiol; 1984 Jun; 47(6):1319-22. PubMed ID: 6204594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Clostridium botulinum toxins type D and C1 in molecular property, antigenicity and binding ability to rat-brain synaptosomes.
    Murayama S; Syuto B; Oguma K; Iida H; Kubo S
    Eur J Biochem; 1984 Aug; 142(3):487-92. PubMed ID: 6468375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Agui T; Iida H; Kubo S
    Infect Immun; 1981 Nov; 34(2):382-8. PubMed ID: 6171518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin.
    Kozaki S; Kamata Y; Nagai T; Ogasawara J; Sakaguchi G
    Infect Immun; 1986 Jun; 52(3):786-91. PubMed ID: 2423459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S; Dufrenne J; Kozaki S
    Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Iida H; Kubo S
    Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A.
    Lyerly DM; Phelps CJ; Wilkins TD
    J Clin Microbiol; 1985 Jan; 21(1):12-4. PubMed ID: 3968199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies.
    Bohach GA; Hovde CJ; Handley JP; Schlievert PM
    Infect Immun; 1988 Feb; 56(2):400-4. PubMed ID: 2448242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal immunisation with Clostridium botulinum type C 16 S toxoid and its non-toxic component.
    Mahmut N; Inoue K; Fujinaga Y; Arimitsu H; Sakaguchi Y; Hughes L; Hirst R; Murphy T; Tsuji T; Watanabe T; Ohyama T; Karasawa T; Nakamura S; Yokota K; Oguma K
    J Med Microbiol; 2002 Oct; 51(10):813-820. PubMed ID: 12435059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the monoclonal antibody response to botulinum neurotoxin type A in the complexed and uncomplexed forms.
    Zhao H; Nakamura K; Kohda T; Mukamoto M; Kozaki S
    Jpn J Infect Dis; 2012; 65(2):138-45. PubMed ID: 22446121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal antibodies to type A, B, E and F botulinum neurotoxins].
    Abbasova SG; Ruddenko NV; Gorokhovatskiĭ AIu; Kapralova MV; Vinogradova ID; Vertiev IuV; Nesmeianov VA; Grishin EV
    Bioorg Khim; 2011; 37(3):344-53. PubMed ID: 21899049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody to type F Clostridium botulinum toxin.
    Ferreira JL; Hamdy MK; McCay SG; Zapatka FA
    Appl Environ Microbiol; 1990 Mar; 56(3):808-11. PubMed ID: 2180373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diversity of neurotoxins from Clostridium botulinum type D strains.
    Moriishi K; Syuto B; Kubo S; Oguma K
    Infect Immun; 1989 Sep; 57(9):2886-91. PubMed ID: 2668193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and evaluation of a monoclonal antibody to Clostridium perfringens type D epsilon toxin.
    El-Enbaawy MI; Abdalla YA; Hussein AZ; Osman RM; Selim SA
    Egypt J Immunol; 2003; 10(1):77-81. PubMed ID: 15719625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of Clostridium botulinum type B toxin to rat brain synaptosome.
    Park MK; Jung HH; Yang KH
    FEMS Microbiol Lett; 1990 Nov; 60(3):243-7. PubMed ID: 2083835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and cytotoxic effects of Clostridium botulinum type A, C1 and E toxins in primary neuron cultures from foetal mouse brains.
    Kurokawa Y; Oguma K; Yokosawa N; Syuto B; Fukatsu R; Yamashita I
    J Gen Microbiol; 1987 Sep; 133(9):2647-57. PubMed ID: 3329217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence homology between tetanus and botulinum toxins detected by an antipeptide antibody.
    Halpern JL; Smith LA; Seamon KB; Groover KA; Habig WH
    Infect Immun; 1989 Jan; 57(1):18-22. PubMed ID: 2909486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.